Skip to main content

Table 2 Demographic and clinical data of study group. Multiple symptoms were possible. Note that data were retrospectively recorded from medical records of patients; no structured interview was performed

From: Gene variants of the SLC2A5 gene encoding GLUT5, the major fructose transporter, do not contribute to clinical presentation of acquired fructose malabsorption

Demographic parameter

Number/frequency

Gender (m/f)

6 (17%)/29 (83%)

Age (years); median (range)

36 (18–68)

Symptoms

 

Abdominal pain

17 (48.6%)

Diarrhoea

12 (34.3%)

Meteorism

5 (14.3%)

Gastroesophageal reflux

5 (14.3%)

Irregular stool frequency

4 ((11.4)

Obstipation

3 (8.6%)

Haematochezia

2 (5.7%)

Not reported in detail

11 (31.4%)

Onset of symptoms

 

Weeks to months

8 (22.9%)

Years

6 (17.1%)

Not recorded

21 (60.0%)

Serological assessment of coeliac disease

 

Anti-deamidated gliadin IgG/IgA antibodies: negative

30/35 (85.7%)

Anti-tissue transglutaminase IgG/IgA: negative

4/35 (11.4%)

No information

1/35 (2.9%)